Ecallantide for the acute treatment of angiotensin-converting enzyme inhibitor-induced angioedema: a multicenter, randomized, controlled trial.

Lewis, Lawrence M; Graffeo, Charles; Crosley, Pascal; Klausner, Howard A; Clark, Carol L; Frank, Anthony; Miner, James; Iarrobino, Ryan; Chyung, Yung

Lewis, Lawrence M; Graffeo, Charles; Crosley, Pascal; Klausner, Howard A; Clark, Carol L; Frank, Anthony; Miner, James; Iarrobino, Ryan; Chyung, Yung.

Affiliation

Lewis LM; Washington University School of Medicine, St. Louis, MO. Electronic address: lewisl@wusm.wustl.edu.
Graffeo C; Eastern Virginia Medical School, Norfolk, VA.
Crosley P; DeKalb Medical Center, Decatur, GA.
Klausner HA; Henry Ford Health System, Detroit, MI.
Clark CL; William Beaumont Hospital, Royal Oak, MI.
Frank A; East Carolina University, Greenville, NC.
Miner J; Hennepin County Medical Center, Minneapolis, MN.
Iarrobino R; Dyax Corp, Burlington, MA.
Chyung Y; Dyax Corp, Burlington, MA.

Ann Emerg Med ; 65(2): 204-13, 2015 Feb.

Article in En | MEDLINE | ID: mdl-25182544

Subject(s)

Angioedema/drug therapy; Angiotensin-Converting Enzyme Inhibitors/adverse effects; Kallikreins/antagonists & inhibitors; Peptides/administration & dosage; Adult; Aged; Aged, 80 and over; Angioedema/chemically induced; Double-Blind Method; Female; Humans; Injections, Subcutaneous; Male; Middle Aged; Treatment Failure

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Angiotensin-Converting Enzyme Inhibitors / Kallikreins / Angioedema Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Ann Emerg Med Year: 2015 Type: Article

Fulltext

XML

PubMed Links

Search on Google